Atlas Trials

Study of 68Ga /131I SGMIB-ZT-199 PET Imaging Targeting HER2-positive in the Diagnosis of Metastatic Breast Cancer

Clinical trial NCT05982626 · UNKNOWN

Trial details

NCT number
NCT05982626
Sponsor
Huashan Hospital
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
HER2-positive Breast Cancer
Start date
2023-05-15
Primary completion
2024-12-31
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.